Renewed Concept of Mastoid Cavity Obliteration with the Use of Temporoparietal Fascial Flap Injected by Injectable Platelet-Rich Fibrin after Subtotal Petrosectomy for Cochlear Implant Patients DOI Creative Commons
Aleksander Zwierz, Krystyna Masna, Paweł Burduk

et al.

Audiology Research, Journal Year: 2024, Volume and Issue: 14(2), P. 280 - 292

Published: March 1, 2024

Background: The subtotal petrosectomy procedure may be useful for cochlear implantation in selected patient groups. Although it is highly effective, complications can arise, which have economic implications the due to high cost of device. Therefore, several authors attempted identify most effective concept obliteration. Methods: We present a pilot descriptive study application techniques obliterating cavities after using temporoparietal fascial flap (TPFF) modified with injectable platelet-rich fibrin (IPRF+) three implant (CI) patients. Results: Our preserves important anatomical structures, such as temporalis muscle, covers CI receiver–stimulator. Injection IPRF+ also increases available tissue volume obliteration and enhances its anti-inflammatory regenerative potential. Conclusions: To best our knowledge, use TPFF filling cavity has not been adopted SP blind sac closure. literature review experience this small group patients suggest that procedure, when combined injections, reduce risk potential infection obliterated cavity, particularly used CI. This technique applicable only cases surgeons are convinced middle ear purged cholesteatoma.

Language: Английский

Blood Plasma, Fibrinogen or Fibrin Biomaterial for the Manufacturing of Skin Tissue-Engineered Products and Other Dermatological Treatments: A Systematic Review DOI Creative Commons
Álvaro Sierra-Sánchez, Raquel Sanabria-de la Torre, Ana Ubago-Rodríguez

et al.

Journal of Functional Biomaterials, Journal Year: 2025, Volume and Issue: 16(3), P. 79 - 79

Published: Feb. 22, 2025

The use of blood plasma, fibrinogen or fibrin, a natural biomaterial, has been widely studied for the development different skin tissue-engineered products and other dermatological treatments. This systematic review reports preclinical clinical studies which it alone combined with biomaterials and/or cells treatment several conditions. Following PRISMA 2020 Guidelines, 147 have revealed that this biomaterial as wound dressing monolayer (one cell type) substitute are preferred strategies, mainly excisional surgical wounds. Moreover, plasma is used although its combination such agarose, polyethylene glycol collagen also reported to increase healing potential. However, most 17 reviewed evaluated severely burned patients bilayer (two types) substitute. Although number evaluating increased during last fifteen years, not correlated wide variety studies. Its safety potential proved; however, lack standard model presence approaches meant translation environment still limited. A higher should be carried out in coming years set strategy each disease.

Language: Английский

Citations

1

Current Progress of Platelet-Rich Derivatives in Cartilage and Joint Repairs DOI Open Access
Meng‐Yi Bai,

Vu Pham Thao Vy,

Sung‐Ling Tang

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(16), P. 12608 - 12608

Published: Aug. 9, 2023

In recent years, several types of platelet concentrates have been investigated and applied in many fields, particularly the musculoskeletal system. Platelet-rich fibrin (PRF) is an autologous biomaterial, a second-generation concentrate containing platelets growth factors form membranes prepared from blood patients without additives. During tissue regeneration, contain higher percentage leukocytes flexible net as scaffold to improve cell migration angiogenic, osteogenic, antibacterial capacities during regeneration. PRF enables release molecules over longer period, which promotes healing The potential simulate physiology immunology wound also due high concentrations released anti-inflammatory cytokines that stimulate vessel formation, proliferation, differentiation. These products used safely clinical applications because their origin minimally invasive nature. We focused on narrative review therapy its effects musculoskeletal, oral, maxillofacial surgeries dermatology. explored components leading biological activity published preclinical research supports application therapy. generally use adjuvant for various chronic muscle, cartilage, tendon injuries. Further trials are needed prove benefits utilizing PRF.

Language: Английский

Citations

19

Clinical and preclinical approach in AGA treatment: a review of current and new therapies in the regenerative field DOI Creative Commons
Lorena Pozo-Pérez, Pilar Tornero-Esteban,

Eduardo López-Bran

et al.

Stem Cell Research & Therapy, Journal Year: 2024, Volume and Issue: 15(1)

Published: Aug. 15, 2024

Abstract Androgenetic alopecia (AGA) is the most prevalent type of hair loss. Its morbility mainly psychological although an increased incidence in melanoma has also been observed affected subjects. Current drug based therapies and physical treatments are either unsuccessful long term or have relevant side effects that limit their application. Therefore, a new therapeutic approach needed to promote regenerative enhancement alternatives. These treatment options, focused on cellular niche restoration, could be solution impact dihydrotestosterone follicle microenvironment. In this context emerging such as Platelet-rich plasma fibrine well stem cells mesenchymal cell derivatives (conditioned medium CM exoxomes) highlighting evolving landscape restoration. Nanotechnology leading way AGA through design bioinks nanobiomaterials whose structures being configuring huge range cases by means 3D bioprinting. Due increasing number rapid creation advanced alternatives field, extended review current state art needed. addition provides general insight which intented guidance for researchers cutting edge recently gaining ground.

Language: Английский

Citations

8

From Blood to Regenerative Tissue: How Autologous Platelet-Rich Fibrin Can Be Combined with Other Materials to Ensure Controlled Drug and Growth Factor Release DOI Open Access
Karīna Egle,

Ilze Šalma,

Arita Dubņika

et al.

International Journal of Molecular Sciences, Journal Year: 2021, Volume and Issue: 22(21), P. 11553 - 11553

Published: Oct. 26, 2021

The purpose of this review is to examine the latest literature on use autologous platelet-rich fibrin as a drug and growth factor carrier system in maxillofacial surgery. Autologous (PRF) unique that combines properties such biocompatibility biodegradability, addition containing factors peptides provide tissue regeneration. This opens up new horizons for all beneficial ingredients blood sample biomedical purposes. By itself, PRF has an unstable effect osteogenesis: therefore, advanced approaches, including combination with materials or drugs, are great interest clinics. main advantage delivery systems by controlling release, high concentrations locally fewer side effects within other can be achieved. especially important tissues limited supply, bone compared soft tissue. ability degrade naturally considered its "warehouse" controlled release systems. We focusing concentrate, it easy manipulations delivered directly surgical site. target audience researchers medical doctors who involved development research PRFs further studies. Likewise, surgeons their work treat patients advice take medicine orally.

Language: Английский

Citations

37

Platelet-Rich Plasma: Advances and Controversies in Hair Restoration and Skin Rejuvenation DOI
Arianne Shadi Kourosh, Kathyana P Santiago Mangual, Ronda S. Farah

et al.

Dermatologic Surgery, Journal Year: 2024, Volume and Issue: 50(5), P. 446 - 452

Published: Feb. 20, 2024

BACKGROUND Platelet-rich plasma (PRP) and its combined therapeutic modalities have catalyzed new possibilities in dermatology; however, limitations evidence lack of consensus remain among clinicians regarding optimal composition, protocol, technique, application. OBJECTIVE To provide an update analysis the for PRP hair restoration skin rejuvenation through review recent available data, highlighting controversies expert insights to guide future studies, stimulate discourse innovations benefitting patients. METHODS A structured PubMed publications before October 2023, with a focus on literature from January 2020 2023. RESULTS AND CONCLUSION Growing supports utility benefits related autologous products applications hair, strongest androgenetic alopecia rejuvenation. However, this is limited by best practices protocols. Randomized, controlled trials uniform metrics comparing outcomes various compositions blood products, preparation methods, dosimetry, frequency treatments are still required. This will allow medical grow beyond realm opinion into consensus, standardization, more wide spread adoption that benefit

Language: Английский

Citations

5

Advancements in Regenerative Medicine for Aesthetic Dermatology: A Comprehensive Review and Future Trends DOI Creative Commons
Federica Trovato,

Stefano Ceccarelli,

Simone Michelini

et al.

Cosmetics, Journal Year: 2024, Volume and Issue: 11(2), P. 49 - 49

Published: March 31, 2024

The growing interest in maintaining a youthful appearance has encouraged an accelerated development of innovative, minimally invasive aesthetic treatments for facial rejuvenation and regeneration. close correlation between tissue repair, regeneration, aging paved the way application regenerative medicine principles cosmetic dermatology. theoretical substrates applications dermo-aesthetics are plentiful. However, dermatology is emerging field needs more data vivo trials to reach consensus on standardization methods. In this review, we summarize techniques as they apply dermatology, suggesting unexplored fields future directions.

Language: Английский

Citations

5

Platelet‐rich fibrin: A review of its role as a new treatment in androgenetic alopecia DOI Creative Commons
Samir Shrestha, Raksha Pathak,

G. C. Jagat

et al.

Journal of Cosmetic Dermatology, Journal Year: 2024, Volume and Issue: 23(8), P. 2524 - 2530

Published: April 20, 2024

Abstract Background Androgenetic alopecia (AGA) is a major cause of hair loss resulting from complex interplay between various genes and hormones with the result being follicular miniaturization altered cycle dynamics. Platelet‐rich plasma (PRP) has well‐established role as adjunctive therapy in AGA but there are many limitations it. In an attempt to overcome shortcomings PRP, liquid platelet‐rich fibrin (PRF) was developed. Aim This article critically reviews protocol for preparation clinical outcomes PRF. Patients/Methods The articles published so far English language regarding PRF were reviewed. Results Among five studies analyzing centrifugation speeds times, three favored low‐speed centrifugation, whereas two did not support this methodology. A horizontal centrifuge may be preferred over fixed‐angle Five on use showed significant effect AGA. Conclusion At present, no consensus Most used low speed less time. Larger needed determine optimal force due higher yield platelets, lesser shear trauma cells. addition, larger, well‐designed confirm benefits PRP.

Language: Английский

Citations

4

Autolougous platelet concentrates in esthetic medicine DOI Creative Commons
Catherine Davies, Richard J. Miron

Periodontology 2000, Journal Year: 2024, Volume and Issue: unknown

Published: July 31, 2024

Abstract This narrative review summarizes current knowledge on the use of autologous platelet concentrates (APCs) in esthetic medicine, with goal providing clinicians reliable information for clinical practice. APCs contain platelets that release various growth factors potential applications facial and dermatologic treatments. examines several APCs, including acne scarring, skin rejuvenation, melasma, vitiligo, stretchmarks, peri‐orbital peri‐oral hair regeneration volumizing effects APC gels. A systematic literature databases (PubMed/MEDLINE) was conducted up to October 2023 identify randomized controlled trials (RCTs) English language rejuvenation dermatology. total 96 articles were selected those rich plasma (PRP), plasma‐rich (PRGF), platelet‐rich fibrin (PRF). Clinical recommendations gained from reviews are provided. In summary, esthetics is a promising yet relatively recent treatment approach. Overall, majority studies have focused PRP positive outcomes. Only few compared versus PRF all demonstrating superior outcomes using PRF. The existing limitations small sample sizes lack standardized assessment criteria. Future research should utilize well‐designed RCTs, incorporating appropriate controls, such as split‐face comparisons, protocols usage, optimal number sessions, interval between objective improvement scores. Nevertheless, most formulations offer an ability improve parameters concerns.

Language: Английский

Citations

4

New tool in our arsenal: efficacy of injectable platelet-rich fibrin (i-PRF) in androgenetic alopecia treatment DOI
S K Yao, Xiaoyan Chen, Sha Li

et al.

Archives of Dermatological Research, Journal Year: 2025, Volume and Issue: 317(1)

Published: Feb. 26, 2025

Language: Английский

Citations

0

Application of injectable platelet-rich fibrin (I-PRF) after posterior tooth removal surgery: a systematic review DOI
Ilan Hudson Gomes de Santana,

Mayara Rebeca Martins Viana,

Julliana Cariry Palhano Dias

et al.

Cell and Tissue Banking, Journal Year: 2025, Volume and Issue: 26(2)

Published: Feb. 27, 2025

Language: Английский

Citations

0